The role of surgery in metastatic cancer: the case for a pragmatic tumor-agnostic randomized trial
Future Oncol
.
2022 Nov;18(36):3955-3959.
doi: 10.2217/fon-2022-0840.
Epub 2023 Jan 9.
Authors
Kerrington Powell
1
,
John Marquart
2
,
Timothée Olivier
3
4
,
Vinay Prasad
4
Affiliations
1
School of Medicine, Texas A&M Health Science Center, Bryan, TX 77807, USA.
2
Department of Surgery, Medical College of Wisconsin, 999 North 92nd Street, Suite CCC 320, Milwaukee, WI 53226, USA.
3
Department of Oncology, Geneva University Hospital, 4 Gabrielle-Perret-Gentil Street, 1205, Geneva, Switzerland.
4
Department of Epidemiology & Biostatistics, University of California San Francisco, 550 16th St, 2nd Fl, San Francisco, CA 94158, USA.
PMID:
36621818
DOI:
10.2217/fon-2022-0840
No abstract available
Keywords:
biomarkers; clinical trials; metastasis; molecular oncology; oncogenes; surgery.
Publication types
Randomized Controlled Trial
MeSH terms
Humans
Neoplasms* / surgery
Neoplasms, Second Primary*
Grants and funding
Arnold Ventures